Salīdzināt metodes

	Dubultaklais A/B tests	Randomizēts kontrolēts pētījums (RCT)
Nozare	Eksperimentu plānošana	Eksperimentu plānošana
Saime	Process / pipeline	Hypothesis test
Izcelsmes gads	1935 (Fisher's formal randomized design); double-blinding in A/B testing: 1990s–2000s	1948
Autors	Evolved from clinical trial methodology; early systematic blinding attributed to James Lind (1753) and formalized by R. A. Fisher (1935)	James Lind (early precursor, 1747); modern formulation: Austin Bradford Hill & Medical Research Council (1948)
Tips	Randomized controlled experiment with blinding	Interventional comparative study
Pirmavots	Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332.	Schulz, K.F., Altman, D.G., Moher, D., for the CONSORT Group (2010). CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials. BMJ, 340, c332.
Citi nosaukumi	double-blind split test, double-blinded A/B experiment, blinded two-arm randomized experiment, double-blind controlled A/B trial	RCT, randomised controlled trial, clinical trial, Randomize Kontrollü Çalışma (RCT) Tasarımı
Saistītās	5	7
Kopsavilkums	A double-blind A/B test is a randomized experiment that compares two variants — a control (A) and a treatment (B) — while concealing group assignment from both participants and those administering or assessing the experiment. Combining the causal isolation of randomized assignment with blinding on both sides eliminates expectation-driven bias from participants and evaluator bias from analysts or administrators, producing cleaner causal estimates of treatment effect.	A randomized controlled trial (RCT) is the gold standard experimental design in clinical and health research, in which participants are randomly allocated to a treatment group or a control group so that the effect of an intervention can be measured with the highest possible degree of internal validity. The modern parallel-group RCT was formalized by Austin Bradford Hill and the Medical Research Council in their landmark streptomycin trial of 1948, and its reporting is governed today by the CONSORT 2010 guidelines (Schulz et al., 2010).